ResMed Inc (RMD)

228.69 -0.81 (-0.35%) USD  |  NYSE  |  Dec 31, 16:00
228.76 +0.07 (+0.03%) Pre-Market: 20:00
More

ResMed Research and Development Expense (Annual): 307.52M for June 30, 2024

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for RMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Boston Scientific Corp 1.414B
Haemonetics Corp 54.44M
Globus Medical Inc 124.01M
Abbott Laboratories 2.741B
Zimmer Biomet Holdings Inc 458.70M